EMBC · NASDAQ
Embecta (EMBC) Stock Price & Fundamentals
Embecta (EMBC) closed at $654.95 on Oct 9, 2026, down 0.29% from the previous close of $656.88.
Share price, past year
1Y +12.06%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $654.95 |
| Sep 30, 2026 | $686.29 |
| Aug 31, 2026 | $679.33 |
| Jul 31, 2026 | $670.78 |
| Jun 30, 2026 | $702.18 |
| May 29, 2026 | $683.24 |
| Apr 30, 2026 | $711.80 |
| Mar 31, 2026 | $716.19 |
| Feb 27, 2026 | $649.31 |
| Jan 30, 2026 | $625.60 |
| Dec 31, 2025 | $613.08 |
| Nov 28, 2025 | $622.77 |
| Oct 31, 2025 | $623.07 |
Key statistics
- Market cap
- $37.11B
- P/E (TTM)
- 361.9
- EPS (TTM)
- $1.81
- Revenue (TTM)
- $1.02B
- Net income (TTM)
- $87.50M
- Shares outstanding
- 56.7M
- Dividend yield
- 0.07%
- 52-week range
- $579.86 – $743.53
Embecta's market cap is $37.11B, based on a share price of $654.95 and 56.7M shares outstanding as of Jun 30, 2026.
Financials
Embecta reported revenue of $1.08B for fiscal 2025, down 3.80% from fiscal 2024.
Embecta earned net income of $95.40M in fiscal 2025, a net margin of 8.8%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Sep 30, 2025 | $1.08B | −3.8% | $95.40M | 8.8% | $1.62 | $182.40M |
| FY2024ended Sep 30, 2024 | $1.12B | +0.2% | $78.30M | 7.0% | $1.34 | $19.90M |
| FY2023ended Sep 30, 2023 | $1.12B | −0.8% | $70.40M | 6.3% | $1.22 | $41.20M |
| FY2022ended Sep 30, 2022 | $1.13B | −3.1% | $223.60M | 19.8% | $3.89 | $388.60M |
| FY2021ended Sep 30, 2021 | $1.17B | +7.4% | $414.80M | 35.6% | $7.28 | $419.50M |
| FY2020ended Sep 30, 2020 | $1.09B | — | $427.60M | 39.4% | $7.50 | $456.60M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2026ended Jun 30, 2026 | $271.70M | $21.10M | $0.36 |
| Q2 FY2026ended Mar 31, 2026 | $221.80M | −$4.10M | −$0.07 |
| Q1 FY2026ended Dec 31, 2025 | $261.20M | $44.10M | $0.74 |
| Q4 FY2025ended Sep 30, 2025 | $264.00M | $26.40M | — |
| Q3 FY2025ended Jun 30, 2025 | $295.50M | $45.50M | $0.78 |
| Q2 FY2025ended Mar 31, 2025 | $259.00M | $23.50M | $0.40 |
| Q1 FY2025ended Dec 31, 2024 | $261.90M | $0.00 | $0.00 |
| Q4 FY2024ended Sep 30, 2024 | $286.10M | $14.60M | — |
Company profile
- Name
- Embecta Corp.
- Ticker
- EMBC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 300 Kimball Drive, Suite 300, Parsippany, NJ 07054
- Incorporated in
- DE
- Fiscal year ends
- September
- SEC CIK
- 0001872789
Recent SEC filings
- Aug 7, 2026
- Aug 7, 2026
- May 15, 2026
- May 5, 2026
- May 5, 2026
- Mar 20, 2026
- Feb 13, 2026
- Feb 5, 2026
Frequently asked questions
What is Embecta's stock price?
Embecta (EMBC) closed at $654.95 on Oct 9, 2026, down 0.29% from the previous close of $656.88.
What is Embecta's market cap?
Embecta's market cap is $37.11B, based on a share price of $654.95 and 56.7M shares outstanding as of Jun 30, 2026.
How much revenue does Embecta make?
Embecta reported revenue of $1.08B for fiscal 2025, down 3.80% from fiscal 2024.
What is EMBC's P/E ratio?
Embecta's price-to-earnings ratio is 361.9, based on trailing twelve-month diluted EPS of $1.81.
Does Embecta pay a dividend?
Yes. Embecta declared $0.46 per share in dividends over the last four quarters, a yield of 0.07%.
Sources and methodology
Fundamentals come from Embecta Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures